Iovance Biotherapeutics Optimizes Headquarters for Cost Efficiency

TipRanks06:49

High Quality 'SMID-cap' Stocks With Cyclical Exposure – MS

Seeking AlphaNov 20 00:47

JMP Securities Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsNov 11 13:31 · Ratings

Iovance Biotherapeutics: Promising Growth and Expansion in Cancer Treatment Fuels Buy Rating

TipRanksNov 11 13:26

A Quick Look at Today's Ratings for Iovance Biotherapeutics(IOVA.US), With a Forecast Between $21 to $32

Futu NewsNov 9 21:00 · Ratings

Express News | Iovance Biotherapeutics Inc : Stifel Cuts Target Price to $21 From $23

BreakingsNov 8 20:29